Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A LINDEMANN

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Blood|November 1, 1994
Cytokine therapy with gene-transfected cells: single injection of irradiated granulocyte-macrophage colony-stimulating factor-transduced cells accelerates hematopoietic recovery after cytotoxic chemotherapy in miceF M Rosenthal, R Früh, R Henschler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltrationW Oster, F Herrmann, H Gamm, et al.
International Journal of Cancer|April 13, 2000
Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cellsA Mackensen, B Herbst, J L Chen, et al.
Leukemia|January 1, 1995
GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia (AML)G Heil, L Chadid, D Hoelzer, et al.
The Journal of Antibiotics|January 5, 2002
Directed biosynthesis of new enniatinsM Krause, A Lindemann, M Glinski, et al.
Biochemical and Biophysical Research Communications|June 5, 1996
Evidence for an alpha helical T cell epitope in the C-terminus of the main birch pollen allergen Bet V 1A J Kungl, M Susani, A Lindemann, et al.
American Journal of Clinical Oncology|January 1, 1991
Clinical effects of recombinant human interleukin-3A Ganser, A Lindemann, G Seipelt, et al.
The Journal of Biological Chemistry|August 9, 1996
Secondary structure and tertiary fold of the birch pollen allergen Bet v 1 in solutionC Faber, A Lindemann, H Sticht, et al.
Blood|May 15, 1992
Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I studyA Ganser, A Lindemann, O G Ottmann, et al.
Leukemia|May 1, 1993
Effect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromesA Ganser, O G Ottmann, G Seipelt, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Blood|November 1, 1994
Cytokine therapy with gene-transfected cells: single injection of irradiated granulocyte-macrophage colony-stimulating factor-transduced cells accelerates hematopoietic recovery after cytotoxic chemotherapy in miceF M Rosenthal, R Früh, R Henschler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltrationW Oster, F Herrmann, H Gamm, et al.
International Journal of Cancer|April 13, 2000
Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cellsA Mackensen, B Herbst, J L Chen, et al.
Leukemia|January 1, 1995
GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia (AML)G Heil, L Chadid, D Hoelzer, et al.
The Journal of Antibiotics|January 5, 2002
Directed biosynthesis of new enniatinsM Krause, A Lindemann, M Glinski, et al.
Biochemical and Biophysical Research Communications|June 5, 1996
Evidence for an alpha helical T cell epitope in the C-terminus of the main birch pollen allergen Bet V 1A J Kungl, M Susani, A Lindemann, et al.
American Journal of Clinical Oncology|January 1, 1991
Clinical effects of recombinant human interleukin-3A Ganser, A Lindemann, G Seipelt, et al.
The Journal of Biological Chemistry|August 9, 1996
Secondary structure and tertiary fold of the birch pollen allergen Bet v 1 in solutionC Faber, A Lindemann, H Sticht, et al.
Blood|May 15, 1992
Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I studyA Ganser, A Lindemann, O G Ottmann, et al.
Leukemia|May 1, 1993
Effect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromesA Ganser, O G Ottmann, G Seipelt, et al.
Pageof 17